Dr. Navid Ezra, MD

Dr. Ezra practices at California Dermatology Institute - Thousand Oaks in Thousand Oaks, California.

Dr. Ezra's NPI, 1104110071, was assigned on June 8, 2011. Dr. Ezra graduated from David Geffen School of Medicine at UCLA in 2011. Dr. Ezra holds California license A135378.

Dr. Ezra's primary practice is California Dermatology Institute - Thousand Oaks, at 3095 Old Conejo Rd, Ste 200, Thousand Oaks, CA 91320. The practice phone is (888) 367-1850.

Dr. Ezra's primary practice is California Dermatology Institute - Thousand Oaks in Thousand Oaks, California. The medical group on file is California Dermatology Institute. Dmand AI also links Dr. Ezra to 1 more physician office and 1 group practice or clinic, each named with a free account. Dr. Ezra's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ezra practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ezra's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ezra is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Ezra's licenses on file in 5 states: California, Nevada, Arizona, Hawaii and Oregon.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and itchy rashes among the conditions Dr. Ezra treats.

CMS data shows 13,305 Medicare services from Dr. Ezra across 42 procedure codes in 2024, for 2,187 Medicare patients. Medicare paid $2,323,771 for them.

CMS counts 2,187 Medicare patients who saw Dr. Ezra in 2024. The largest group is 65 to 74, with 1,047 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 78% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ezra's median patient age at 47, with 59% women.

In 2024, Dr. Ezra wrote 9,418 Medicare Part D claims for 1,791 patients. 93% of them were for generic drugs. CMS names the drug for 9,226 of them, across 55 drugs with 11 or more claims each, at $3,445,385 in total drug cost. In 2023, CMS named 8,962 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ezra for performance year 2024, reported individually. Dr. Ezra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ezra as offering telehealth. CMS counts 5,358 procedures of removal of skin lesions by Dr. Ezra, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 29 papers to Dr. Ezra, published from 2009 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Cicatrix, Dermatologic Agents and Adrenal Cortex Hormones. Dr. Ezra has published most often in Clin Exp Dermatol. Dr. Ezra's most frequent co-authors are Ashish Arshanapalli, Daniel Shahrooz Behroozan, MD and Anand K. Ganesan, MD.

Dmand AI links Dr. Ezra to 5 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Arthritis, Psoriatic, Dermatitis, Atopic and Lupus Erythematosus, Systemic. Sun Pharmaceutical Industries Limited sponsors the most, 3. Open Payments lists research payments to Dr. Ezra that name 4 trials.

CMS Open Payments shows 1,168 general payments to Dr. Ezra from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Abbvie Inc. paid the most, $265,088. It also lists 25 research payments totaling $37,027 from 2019 to 2024, naming 4 clinical trials.

Dr. Ezra graduated from David Geffen School of Medicine at UCLA in 2011.

Dr. Ezra is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and LA Care. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.